Envestors
Other
Active
London, United Kingdom
20
7M
16
1.05
5
0.20
2
- Stages of investment
- Areas of investment
Summary
Envestors appeared to be the Corporate Investor, which was created in 2004. The leading representative office of defined Corporate Investor is situated in the London. The fund was located in Europe if to be more exact in United Kingdom.
The fund has no specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Financial Exchanges, Fertility. Among the most popular portfolio startups of the fund, we may highlight Lightpoint Medical, Ebury, Cipher Surgical. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The important activity for fund was in 2011. This Envestors works on 21 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 1 - 5 millions dollars are the general things for fund. Considering the real fund results, this Corporate Investor is 18 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2019.
The fund was created by Nick Taylor, Oliver Woolley, Scott Haughton. The overall number of key employees were 3.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Envestors, startups are often financed by Midven, Angels 5K, Minerva Business Angel Network. The meaningful sponsors for the fund in investment in the same round are SyndicateRoom, Oxford Technology Management, Cambridge Capital Group. In the next rounds fund is usually obtained by SyndicateRoom, 83North, The FSE Group.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 20
- Lead investments
- 5
- Exits
- 2
- Rounds per year
- 1.05
- Follow on index
- 0.20
- Investments by industry
- Medical Device (4)
- Medical (4)
- Software (4)
- Health Care (4)
- Manufacturing (3) Show 42 more
- Investments by region
-
- Canada (1)
- United Kingdom (16)
- South Korea (3)
- Peak activity year
- 2011
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 149M
- Group Appearance index
- 0.50
- Avg. company exit year
- 8
- Avg. multiplicator
- 4.06
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Lightpoint Medical | 30 Dec 2014 | Biotechnology, Medical Device, Medical | Early Stage Venture | 1M | United Kingdom, England |
Willog | 12 Oct 2023 | Logistics, Supply Chain Management, Transportation, Software, Information Technology | Early Stage Venture | Seoul, Seoul-t'ukpyolsi, South Korea |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.